PRESS RELEASE
News
-
-
-
PRESS RELEASE
Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
Sonnet BioTherapeutics successfully completes Phase 1b trial of SON-080 with positive safety profile, paving the way for Phase 2 trial in Diabetic Peripheral Neuropathy (DPN) after potential partnership -
PRESS RELEASE
Pampa Metals Intersects 304m at 1.07% CuEq* incl. 132m at 1.45% CuEq* from First Drillhole at the Piuquenes Porphyry Project, Argentina
Pampa Metals Corp. reports assay results for diamond drillhole PIU-01 at Piuquenes Central porphyry target in Argentina. Significant Cu-Au mineralization observed -
-
PRESS RELEASE
Predictmedix AI Expands Strategic Partnerships with Samyak Solutions Inc. and Manchester Marketing Group Inc. for Safe Entry Distribution in the US Market
Predictmedix partners with Samyak Solutions Inc. & Manchester Marketing Group Inc. to distribute Safe Entry Stations in the US. The AI-powered health screening solution aims to enhance safety in various settings -
-
PRESS RELEASE
Your Family Entertainment AG (WKN: A161N1, ISIN: DE000A161N14, abbreviation: RTV) now also listed in the m:access segment of the Munich Stock Exchange
Your Family Entertainment AG is now listed in the m:access segment of the Munich Stock Exchange, broadening its investor base. The move demonstrates the company's commitment to transparency and quality -
PRESS RELEASE
Original-Research: Media and Games Invest SE (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research updates Media and Games Invest SE (ISIN: SE0018538068) with BUY rating and increased target price to EUR 3.60, citing Q4 revenue beat and optimistic outlook for 2024 -
PRESS RELEASE
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Alzchem Group AG and Crearene AG achieve successful addition of creatine to dialysis patient treatments, demonstrating technical feasibility and patient safety. Collaboration extended for medical applications
